Leading pathology laboratories deploy tele-diagnostics with Philips during the COVID-19 pandemic
November 18 2020 - 9:00AM
Leading pathology laboratories deploy tele-diagnostics with Philips
during the COVID-19 pandemic
November 18, 2020
- Pathology laboratories around the globe fully digitize tumor
tissue samples to maintain the patient diagnostic experience while
providing for staff safety
- Digital transformation modernizes cancer care by enabling
telehealth and the use of artificial intelligence (AI) while
supporting physicians with integrated oncology informatics
Amsterdam, The Netherlands – Royal Philips (NYSE: PHG,
AEX: PHIA), a global leader in health technology, today announced
leading pathology laboratories across North America, Europe, and
Asia have implemented full digitization for their histology samples
based on the Philips Digital Pathology scanner and
imaging-informatics solutions. Digital images are required to
unlock the potential of digital pathology. Remote reviewing of
pathological cases is essential to prevent delay in critical
patient diagnosis and care, particularly during COVID-19.
During the pandemic, many pathologists, oncologists, and
radiologists continued their work from home. This created an
unprecedented need for home workstations and secure clinical
informatics solutions allowing clinicians to read images remotely
and enabling real-time virtual collaboration between their
multi-disciplinary care teams. Pre-COVID-19, pathology labs that
digitized their workflows across different sites
reported improved collaboration and an average
productivity gain of 21%.
Examples of leading pathology laboratories that recently
transformed towards a digital workflow with Philips IntelliSite
Pathology Solution are: Mackenzie Health (Canada), Pathology
Institute Tel Aviv Sourasky MC (Israel), University Medical Center
Groningen (Netherlands), St. Olavs Hospital (Norway), Singapore
General Hospital SGH (Singapore), Oxford University Hospitals NHS
(UK), and NHS Ayrshire & Arran (UK).
“As healthcare becomes more complex and demanding, digitization
has become a key enabler for the hospital to provide better care
for our patients and to be more efficient. Digital pathology is an
example, and our partnership with companies such as Philips with
the clinical and technical know-how is important in helping us
achieve our goal,” said Prof. Kenneth Kwek, Chief Executive Officer
at Singapore General Hospital SGH.
“COVID-19 has become a catalyst for change – a defining moment
for all of us to reimagine healthcare the way it should be,” said
Kees Wesdorp, Chief Business Leader, Precision Diagnosis at
Philips. ”With a focus on the people at the center of cancer care,
we work to innovate workflows, remove barriers of fragmented
systems, and bring insights directly to care providers to support
excellent cancer care.”
Shared decision-making, pathway selection and
treatmentPhilips’ solutions for oncology and digital pathology
can help transform and enhance the multi-disciplinary workflows,
including the oncology tumor board and care pathways process.
Critical patient data is integrated for both oncologists,
radiologists and pathologists, allowing them to collaborate
efficiently, even when working remotely. The Philips platform
supports streamlined preparation, enhances review and analysis, and
empowers the cancer care team to reach clinical treatment decisions
based on disease-specific dashboards, diagnostic images, reports,
and structured patient data. Visit Philips Digital Pathology for
more information on how Philips is enhancing digital pathology
workflows. Visit Philips Live at RSNA 2020 to learn how
Philips integrated workflow solutions connect data, technology and
people across the diagnostic enterprise, helping to redefine
radiology workflow efficiencies. For further information, please
contact:
Kathy O’ReillyPhilips Global Press OfficeTel.: +1
978-221-8919E-mail : kathy.oreilly@philips.comTwitter:
@kathyoreilly
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2019 sales of EUR 19.5 billion and
employs approximately 81,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Digital pathology at Singapore General Hospital
- Digital-Award-Hoogeveen
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Sep 2023 to Sep 2024